menaquinone-6 and Dermatitis--Atopic

Vitamin K2 is suggested to have a suppressive effect on the peripheral blood mononuclear cells (PBMCs) of pediatric atopic dermatitis patients. We examined the molecular targets of vitamin K2 to suppress proliferation and cytokine production in T-cell mitogen-activated PBMCs of atopic dermatitis patients from the viewpoint of mitogen-activated protein kinase signaling molecules. The study population included 16 pediatric vitamin K2 patients and 21 healthy subjects. The effect of vitamin K2 on concanavalin A-activated PBMC proliferation was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and cell counting assays. T-helper (Th)1/Th2/Th17 cytokine profiles in plasma and PBMC-culture supernatants were analyzed by a cytometric beads array assay. Mitogen-activated protein kinase signaling molecules in concanavalin A-activated PBMCs were examined by enzyme-linked immunosorbent assay (ELISA) assays. At 10-100 µM, vitamin K2 significantly suppressed the proliferation of mitogen-activated PBMCs derived from atopic dermatitis patients and healthy subjects (p < 0.05). The interleukin (IL)-10 concentrations in plasma and the PBMC culture supernatants of atopic dermatitis patients were significantly higher than those of healthy subjects (p < 0.05). The IL-2 concentrations in the culture supernatants of atopic dermatitis PBMCs were significantly lower than those of healthy PBMCs (p < 0.05). Vitamin K2 significantly inhibited the IL-17A, IL-10, and tumor necrosis factor α (TNF-α) production (p < 0.05), and increased the IL-2 production (p < 0.01) in the culture supernatant of atopic dermatitis PBMCs. At 10-100 µM, vitamin K2 markedly decreased the of Mek1, extracellular signal-regulated kinases (ERK)1/2 mitogen-activated protein kinase, and SAPK/c-Jun N-terminal kinase (JNK) expression in atopic dermatitis PBMCs (p < 0.05). Vitamin K2 is suggested to attenuate activated T-cell immunity in atopic dermatitis patients through the inhibition of mitogen-activated protein kinase-Mek1-ERK1/2 and SAPK/JNK signaling pathways.

Topics: Adolescent; Adult; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Cytokines; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Humans; Infant; Inflammation Mediators; Leukocytes, Mononuclear; Lymphocytes; Male; Mitogen-Activated Protein Kinases; Vitamin K 2; Young Adult

We estimated the pharmacological efficacy of vitamin K

Topics: CD4 Lymphocyte Count; Cell Proliferation; Cells, Cultured; Child; Concanavalin A; Dermatitis, Atopic; Humans; Interleukin-10; Interleukin-2; Leukocytes, Mononuclear; Mitogens; T-Lymphocytes, Regulatory; Vitamin K 1; Vitamin K 2; Vitamins

Novel actinobacterial strains, PAGU 1247(T), PAGU 1251 and PAGU 1252, were isolated from the skin of atopic dermatitis patients and were characterized using a polyphasic approach. Phylogenetic analyses based on 16S rRNA gene sequences showed that these isolates were located within the family Dermacoccaceae. The most closely related species of PAGU 1247(T) in phylogenetic terms was Branchiibius hedensis Mer 29717(T), with 16S rRNA gene sequence similarity of 99.6%, although the DNA-DNA relatedness value was less than 43.9%. Some biochemical traits, such as lipase (C14) and α-galactosidase activity, could distinguish these isolates from B. hedensis. Strain PAGU 1247(T) contained iso-C(16:0) and brC(18:0) as the major fatty acids. The quinone system consisted of menaquinone MK-8(H(6) and H(4)). The G+C content of the genomic DNA was 67.6mol%. On the basis of its phenotypic properties and genetic distinctiveness, strains PAGU 1247(T), PAGU 1251 and PAGU 1252 represents a novel species of the genus Branchiibius, for which the name Branchiibius cervicis sp. nov. is proposed. The type strain is PAGU 1247(T) (=NBRC 106593(T)=DSM 24166(T)).

Topics: Actinomycetales; Actinomycetales Infections; Adolescent; Adult; Base Composition; Cell Wall; Chromatography, High Pressure Liquid; Dermatitis, Atopic; DNA, Bacterial; Fatty Acids; Female; Genes, Bacterial; Genes, rRNA; Humans; Male; Neck; Phenotype; Phylogeny; Ribotyping; RNA, Ribosomal, 16S; Vitamin K 2; Young Adult